GANX
Gain Therapeutics, Inc. Common Stock
$1.81
-3.70%
-0.07
Notify me if price changes either direction
Buy GANX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
70.4M
Enterprise value
60.0M
Trailing PE
-2.0449438791596
Forward PE
-2.076923
PEG Ratio
0.17382022972857
Enterprise to EBITDA
-3.419
Price to book MRQ
11.52439
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
EBITDA
-17553668
Diluted EPS TTM
-0.61
Total Cash (MRQ)
8.8M
Current ratio (MRQ)
2.522
Operating Cash Flow (TTM)
-17301580
GANX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
